Group Chief Financial Officer

Carsten Dehning

Carsten Dehning

Carsten Dehning

Group Chief Financial Officer

Carsten has over 16 years of experience as a Chief Financial Officer, Chief Executive Officer and Board Member in the healthcare industry where he has been involved in the management of early stage drug discovery ventures to projects from early to late stages of clinical development.

In these functions, Carsten has been instrumental in the design and execution of the corporate and clinical strategy. In addition to his deep understanding of all aspects of financial control and investor relations he brings to Bourn Hall considerable experience in the structuring and execution of corporate development transactions and M&A deals. Carsten holds a Diploma in business administration from the University of Göttingen, Germany.